| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 研发项目(元) | 1,548,237,291.00 | 1,043,182,061.00 | 751,753,090.00 | 385,019,641.00 |
| 医药制造业(元) | 19,166,056,039.00 | 9,323,763,721.00 | 17,725,500,817.00 | 8,538,981,811.00 |
| 其他(元) | - | 366,980,827.00 | 435,399,556.00 | - |
| 营业成本(元) | ||||
| 研发项目(元) | 748,819,711.00 | 337,202,865.00 | 251,816,331.00 | 112,139,718.00 |
| 医药制造业(元) | 8,921,457,077.00 | 4,384,958,039.00 | 8,404,562,289.00 | 3,927,310,251.00 |
| 其他(元) | - | 292,842,502.00 | 302,820,546.00 | - |
| 毛利(元) | ||||
| 研发项目(元) | 799,417,580.00 | 705,979,196.00 | 499,936,759.00 | 272,879,923.00 |
| 医药制造业(元) | 10,244,598,962.00 | 4,938,805,682.00 | 9,320,938,528.00 | 4,611,671,560.00 |
| 其他(元) | - | 74,138,325.00 | 132,579,010.00 | - |
| 毛利率(%) | ||||
| 研发项目(%) | 51.63 | 67.68 | 66.50 | 70.87 |
| 医药制造业(%) | 53.45 | 52.97 | 52.58 | 54.01 |
| 其他(%) | - | 20.20 | 30.45 | - |
| 收入构成(%) | ||||
| 研发项目(%) | 7.47 | 9.72 | 3.97 | 4.31 |
| 医药制造业(%) | 92.53 | 86.86 | 93.72 | 95.69 |
| 其他(%) | - | 3.42 | 2.30 | - |
| 毛利构成(%) | ||||
| 研发项目(%) | 7.24 | 12.34 | 5.02 | 5.59 |
| 医药制造业(%) | 92.76 | 86.36 | 93.65 | 94.41 |
| 其他(%) | - | 1.30 | 1.33 | - |